cetirizine has been researched along with Acantholytic Dyskeratotic Epidermal Nevi in 1 studies
Cetirizine: A potent second-generation histamine H1 antagonist that is effective in the treatment of allergic rhinitis, chronic urticaria, and pollen-induced asthma. Unlike many traditional antihistamines, it does not cause drowsiness or anticholinergic side effects.
cetirizine : A member of the class of piperazines that is piperazine in which the hydrogens attached to nitrogen are replaced by a (4-chlorophenyl)(phenyl)methyl and a 2-(carboxymethoxy)ethyl group respectively.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Cetirizine was initiated at 10 mg daily and increased to 40 mg daily over four weeks, with resultant marked improvement of the patient’s burning sensation." | 1.51 | Vesiculobullous Darier Disease Symptomatically Responsive to Cetirizine ( Brinster, N; Lederhandler, MH; Soter, NA; Wang, JF, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, JF | 1 |
| Lederhandler, MH | 1 |
| Brinster, N | 1 |
| Soter, NA | 1 |
1 other study available for cetirizine and Acantholytic Dyskeratotic Epidermal Nevi
| Article | Year |
|---|---|
Vesiculobullous Darier Disease Symptomatically Responsive to Cetirizine
Topics: Anti-Allergic Agents; Cetirizine; Darier Disease; Dose-Response Relationship, Drug; Eosinophils; Fem | 2019 |